Citibank: Initiates a 30-day bullish observation period on TOPSPORTS (06110) with a "buy" rating.
Citi expects that the future Nike China leadership team will be able to obtain more global authorizations, greater operational flexibility, and richer brand resources, driving the recovery of the Chinese market business (accounting for approximately 50% to 60% of total revenue) next year.
Citibank released a research report stating that it will conduct a 30-day observation period for TOPSPORTS (06110) to identify potential catalysts for upward movement. It pointed out that Nike recently announced a major senior management adjustment, putting the brand president and regional leaders at the same level, with the aim of streamlining the structure. Citibank predicts that the Nike China leadership team will be able to obtain more global authorizations, greater operational flexibility, and richer brand resources in the future, which will drive the Chinese market business (accounting for approximately 50% to 60% of TOPSPORTS sales) to recover next year. Citibank gave TOPSPORTS a target price of 3.75 Hong Kong dollars and a rating of "buy".
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






